Capsimax
Power your weight management and sports nutrition formulation with clinically studied, multifunctional support of Capsimax.
Differentiating with Capsimax
Capsimax is produced using OmniBead smart coating technology to encapsulate clinically studied levels of capsaicinoids, enabling efficacious delivery while helping improve gastrointestinal tolerability.
- Supported by 7 clinical studies across weight management and sports nutrition applications.*17
- Stimulant-free and safe, with no impact on heart rate, blood pressure, or catecholamines.*1,2,5,6
- Manufactured in ISO-22000 (2005), BRC and cGMP certified facilities
- Kosher, and halal certified
- Original Capsimax is available in OmniBead vegetarian beadlets suitable for capsules, tablets, and beverage-grade dry powders (RTMs)
- Capsimax Next is available as an Evobead-powered SKU optimized for capsule and tablet delivery formats
Connect with our experts to explore how this ingredient can elevate your next formulation
Contact Our Experts
- SupplySide West Editor’s Choice Award in partnership with GNC for innovation in the weight management category, 2013
- N. America
- EU
- AMEA
- ANZ
Science Overview
Derived from red chili peppers (Capsicum annuum), Capsimax harnesses the metabolic activity of capsaicinoids to support multiple key pathways involved in weight management and sports nutrition, all in one small 100 mg dose.*17
Metabolism and thermogenesis
In clinical studies, Capsimax supported resting energy expenditure, contributing to a burn total of approximately 104 calories over a 4-hour period at rest.*1,2 Capsimax also promotes thermogenic activity.*2
Appetite management
In a randomized, placebo-controlled study, Capsimax reduced appetite and caloric intake.*4
Natural GLP-1 support
Clinical data demonstrated support for natural GLP-1 production after 7 days of supplementation.*3
Exercise performance
Clinically shown to help support exercise intensity from day 1 and muscle endurance.*3
Lipolysis
Capsimax increased serum levels of free fatty acids and glycerol, supporting the breakdown of stored fat for use as energy substrates.*5
Safety profile
Capsimax has been shown to be safe and stimulant-free, with no impact on heart rate, blood pressure, or catecholamines.*1,2,5,6
The OmniActive difference means clinical expertise.
Speak with our experts to learn more about the scientific research behind this ingredient.
Technology
Capsimax is powered by OmniBead delayed-release technology to help deliver clinically studied levels of capsaicinoids with improved gastrointestinal tolerability, while Capsimax Next leverages Evobead coreless coating technology to enable higher loading capacity and enhanced manufacturing efficiency. Together, these platforms provide targeted release, optimized dose delivery, and greater formulation flexibility with scalable performance.
What does this mean for your formulation?
Overcoming sensory challenges
Controlled release beadlet technology enables efficacious capsaicinoid levels without gastric discomfort.
Low-dose efficacy = formulation flexibility
Clinically studied performance at just 100 mg supports smaller dosage forms and flexibility to incorporate complementary actives without increasing pill burden.
Expanded delivery options
Omnibead is suitable for capsules, tablets, and beverage-grade powders.
Maintaining consumer confidence
Strong clinical backing, with experiential day 1 benefits on metabolic rate and exercise intensity and stimulant-free positioning reinforce credibility in weight management and sports nutrition formulas.
The OmniActive Difference
Innovation and solutions for your most complex formulation challenges.
Contact Us to find out moreConsumer Site
capsimax.com
To learn more about Capsimax and explore how to find premium finished products formulated with an efficacious dose of Capsimax.
visit capsimax.com.Be Featured
If you are a brand formulating with Capsimax or Capsimax Next and would like to be featured on our consumer site.
Contact Us* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
References
- Deng Y, Zhang Y, Li J, et al. Capsaicinoids and capsinoids: A potential role for weight management? Advances in Nutrition. 2017;8(3):469–476.
- Morde A, Patel H, Rangari V. Efficacy and safety of Capsimax in healthy overweight subjects: A randomized, double-blind, placebo-controlled study. Journal of Obesity and Overweight. 2017;7(2):201.
- Capsimax Exercise Performance and GLP-1 Study. Randomized, placebo-controlled clinical evaluation of Capsimax on GLP-1 response and exercise performance. Manuscript under review; January 2026.
- Rogers J, et al. Capsimax reduces appetite and caloric intake in overweight individuals: A randomized, placebo-controlled study. BMC Obesity. 2018;5:17. Published August 13, 2018.
- Bloomer RJ, Canale RE, Blankenship MM, et al. Effect of oral capsaicinoid supplementation on plasma free fatty acids, glycerol, and metabolic markers in healthy adults. Lipids in Health and Disease. 2010;9:72.
- Deshpande J, et al. Safety evaluation of a novel capsaicinoid formulation in healthy subjects. Journal of Toxicology. 2016;2016:9063054. Published March 15, 2016.
- Lopez HL, Ziegenfuss TN, Hofheins JE, et al. Eight weeks of supplementation with a capsaicinoid formulation enhances fat oxidation and exercise performance in healthy adults. Journal of the International Society of Sports Nutrition. 2013;10:21. Published April 19, 2013.